For inquiries about cancer management and effectiv
Effective Implementation of the Press Pulse Protocol
Press/Pulse: A Sustainable Approach to Managing Cancer
Emerging evidence suggests that cancer management should consider cancer as fundamentally a metabolic mitochondrial disease, rather than merely a consequence of somatic mutation. This paradigm shift has sparked increased interest in metabolic therapies, particularly Dr. Thomas Seyfried's Press/Pulse protocol, which offers a non-toxic and sustainable approach to managing tumour burden.
The Press/Pulse protocol specifically targets the metabolic pathways that cancer cells utilize for energy production, focusing on the fermentation of glucose and glutamine. By chronically lowering glucose availability while supplying non-fermentable ketone bodies, this metabolic therapy aims to degrade tumour viability and enhance survivorship, aligning with principles of the ketogenic diet.
Participation in the coherent and effective implementation of Press/Pulse through independent, patient-driven administration is significantly extending survivorship in cancer management beyond what the Standard of Care can offer alone. This is especially evident in the successful application of dietary ketogenic metabolic therapy in patients with glioblastoma, as demonstrated in a clinical study by Dr. Thomas Seyfried. Working in a collaborative and supportive environment to explore the key elements of metabolic therapies allows you to navigate the challenges of implementation with ongoing support and guidance.
the press/pulse protocol
To press and to pulse
Based on the understanding that the common phenotype of all cancers is an energetic reliance on the fermentation of glucose and glutamine due to the loss or inhibition of normative cellular respiration in the form of oxidative phosphorylation, Press/Pulse targets these key metabolic pathways, degrading tumor viability in the context of effective cancer management.
Press/Pulse is a term borrowed from paleobiology; a Press disturbance shifts the adaptive landscape, while a Pulse disturbance is an acute event that disrupts biological functions, producing high mortality. We consider the Press/Pulse concept in light of current views on the origin of cancer, as discussed by Dr. Thomas Seyfried.
Press: A sustained reduction of glucose availability through a controlled ketogenic diet, whereby the body relies on ketones for energy—something cancer cells cannot ferment into ATP. This phase also incorporates mebendazole, an antiparasitic drug shown to inhibit cancer cell growth, along with stress management techniques, since chronic stress can elevate glucose levels and fuel cancer metabolism.
Pulse: Periodic, targeted interventions including glutamine inhibition and hyperbaric oxygen therapy (HBOT). By restricting the availability of cancer’s secondary fuel source—glutamine—metabolic stress is created. HBOT further amplifies this stress by flooding cancer cells with oxygen, upregulating reactive oxygen species. This leads to increased oxidative stress, pushing cancer cells closer to death while leaving healthy cells unharmed.
By combining these metabolic therapies, the protocol disrupts cancer’s energy supply, weakens tumor cells, and enhances the body’s natural ability to fight disease, all while protecting healthy cells.
CALL TO ACTION
Explore the Press/Pulse protocol further and consider its potential benefits for cancer management for yourself or your loved ones. Connect with Kathryn Grace for personalized guidance and support in implementing the Press/Pulse protocol alongside insights from Dr. Thomas Seyfried on the ketogenic diet. Join the growing community embracing metabolic therapies and metabolic therapy as a path toward a healthier future.